blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0652968

EP0652968 - DEFECTIVE ADENOVIRUSES [Right-click to bookmark this link]
Former [1995/20]DEFECTIVE ADENOVIRUSES AND CORRESPONDING COMPLEMENTATION LINES
[2000/47]
StatusNo opposition filed within time limit
Status updated on  28.12.2001
Database last updated on 24.04.2024
Most recent event   Tooltip28.12.2001No opposition filed within time limitpublished on 13.02.2002  [2002/07]
Applicant(s)For all designated states
TRANSGENE S.A.
11, rue de Molsheim
67082 Strasbourg Cédex / FR
[1997/06]
Former [1995/20]For all designated states
TRANSGENE S.A.
11, rue de Molsheim
F-67000 Strasbourg / FR
Inventor(s)01 / IMLER, Jean-Luc
5a, rue des Mineures
F-67000 Strasbourg / FR
02 / METHALI, Majid
16 Impasse de Reims
F-67400 Illkirch-Graffenstaden / FR
03 / PAVIRANI, Andréa
11 rue de la Baronne d'Oberkirch
F-67000 Strasbourg / FR
[1995/20]
Representative(s)Barth, Renate, et al
Vossius & Partner
Postfach 86 07 67
81634 München / DE
[N/P]
Former [1998/38]Barth, Renate, Dr., et al
Vossius & Partner Postfach 86 07 67
81634 München / DE
Former [1995/20]Warcoin, Jacques, et al
Cabinet Régimbeau, 26, avenue Kléber
F-75116 Paris / FR
Application number, filing date94917063.327.05.1994
[1995/20]
WO1994FR00624
Priority number, dateFR1993000648228.05.1993         Original published format: FR 9306482
[1995/20]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9428152
Date:08.12.1994
Language:FR
[1994/27]
Type: A1 Application with search report 
No.:EP0652968
Date:17.05.1995
Language:FR
The application published by WIPO in one of the EPO official languages on 08.12.1994 takes the place of the publication of the European patent application.
[1995/20]
Type: B1 Patent specification 
No.:EP0652968
Date:21.02.2001
Language:FR
[2001/08]
Search report(s)International search report - published on:EP08.12.1994
ClassificationIPC:C12N15/861, C12N5/10, A61K39/235, A61K48/00, C12N15/12, C12N15/31, C12N7/04
[2000/47]
CPC:
C07K14/005 (EP,US); C07K14/395 (EP,US); C07K14/4712 (EP,US);
C07K14/57 (EP,US); C12N15/86 (EP,US); C12N7/00 (EP,US);
A61K35/12 (EP,US); A61K38/00 (EP,US); A61K48/00 (EP,US);
C12N2710/10322 (EP,US); C12N2710/10343 (EP,US); C12N2710/10352 (EP,US);
C12N2710/10362 (EP,US); C12N2830/00 (EP,US); C12N2830/002 (EP,US);
C12N2830/15 (EP,US); C12N2830/60 (EP,US); C12N2840/20 (EP,US) (-)
Former IPC [1995/20]C12N15/86, C12N15/34, C12N5/10, A61K48/00, C12N15/12, C12N7/04, C12N15/23, A61K39/235, C12N15/31
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/20]
TitleGerman:DEFEKTE ADENOVIREN[2000/47]
English:DEFECTIVE ADENOVIRUSES[2000/47]
French:ADENOVIRUS DEFECTIFS[2000/47]
Former [1995/20]DEFEKTIVE ADENOVIREN UND ENTSPRECHENDEN TRANSKOMPLEMENTANTEN ZELLLINIEN
Former [1995/20]DEFECTIVE ADENOVIRUSES AND CORRESPONDING COMPLEMENTATION LINES
Former [1995/20]ADENOVIRUS DEFECTIFS ET LIGNEES DE COMPLEMENTATION CORRESPONDANTES
Entry into regional phase30.01.1995National basic fee paid 
30.01.1995Designation fee(s) paid 
10.04.1995Examination fee paid 
Examination procedure10.04.1995Examination requested  [1995/23]
14.04.1998Request for accelerated examination filed
18.06.1998Despatch of a communication from the examining division (Time limit: M06)
18.06.1998Decision about request for accelerated examination - accepted: Yes
27.11.1998Reply to a communication from the examining division
05.03.1999Despatch of a communication from the examining division (Time limit: M04)
14.07.1999Reply to a communication from the examining division
27.09.1999Despatch of a communication from the examining division (Time limit: M04)
11.11.1999Reply to a communication from the examining division
07.04.2000Despatch of a communication from the examining division (Time limit: M04)
18.05.2000Reply to a communication from the examining division
26.10.2000Despatch of communication of intention to grant (Approval: Yes)
10.11.2000Fee for grant paid
10.11.2000Fee for publishing/printing paid
06.12.2000Communication of intention to grant the patent
Divisional application(s)EP01111931.0  / EP1149916
EP98124036.9  / EP0919624
EP98124037.7  / EP0919625
EP98124038.5  / EP0919626
EP98124039.3  / EP0919627
Opposition(s)22.11.2001No opposition filed within time limit [2002/07]
Fees paidRenewal fee
29.04.1996Renewal fee patent year 03
21.04.1997Renewal fee patent year 04
20.04.1998Renewal fee patent year 05
28.05.1999Renewal fee patent year 06
30.05.2000Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9306223  (CENTRE NAT RECH SCIENT [FR]) [A] 1 * claim 3 *;
 [E]WO9412649  (GENZYME CORP [US]) [E] 1-10,15,24,26,27,30-32,42,43,46,49,50,52-55* the whole document *;
 [A]  - BABISS, L.E., "The cellular transcription factor E2F requires viral E1A and E4 gene products for increased DNA-binding activity and functions to stimulate adenovirus E2A gene expression", JOURNAL OF VIROLOGY, (198906), vol. 63, no. 6, pages 2709 - 2717, XP000999846 [A] 1,2 * page 2715, column 2, line 53 - line 54 * * page 2716, column 1, line 6 - line 9 *
 [A]  - STATFORD-PERRICAUDET, L. & PERRICAUDET, M., "Gene transfer into animals: the promise of adenovirus", HUMAN GENE TRANSFER, (1991), vol. 219, pages 51 - 61, XP002105749 [A] 1 * page 58, paragraph 6 *
 [A]  - ROSENFELD, M.A. ET AL., "In vivo transfer of the human cystic fibrosis transmembrane conductance gene to the airway epithelium", CELL., CAMBRIDGE, NA US, (19920110), vol. 68, no. 1, pages 143 - 155, XP002064228 [A] 9-11 * the whole document *

DOI:   http://dx.doi.org/10.1016/0092-8674(92)90213-V
ExaminationWO9408026
 WO9411506
 WO9424297
 WO9425073
 WO9426915
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.